Review reveals how glioblastoma tumors exploit neuropeptide signaling pathways including NPY, substance P, and others to promote growth, invasion, and immune evasion.
Brain tumors exploit NPYGlioblastoma hijacks neuropeptide signaling for growth and immune evasion — revealing potential new treatment targets
What the researchers found
Glioblastoma exploits neuropeptide signaling (NPY, substance P, others) for tumor growth, invasion, and immune evasion, revealing potential therapeutic targets.
Why it matters
Glioblastoma has a median survival of ~15 months with no cure. Targeting the neuropeptide pathways these tumors depend on could provide entirely new treatment approaches.
The numbers in context
Not specified — broad review covering multiple neuropeptide families and their roles in GBM.
How the study worked
Comprehensive review of neuropeptide signaling roles in glioblastoma biology, including tumor growth, invasion, and immune microenvironment.
Who was studied
N/A — review of neuropeptide signaling research in glioblastoma
What this study cannot tell us
Review of a complex field with most evidence preclinical. Targeting neuropeptide pathways in the brain is challenging due to their normal physiological roles.
How to read the evidence
Moderate evidence: comprehensive review of preclinical evidence identifying neuropeptide-tumor interactions.
When this study was published
Published in 2025. Captures the latest understanding of neuropeptide roles in glioblastoma.
The bigger picture
The nervous system-cancer interaction is an emerging frontier. Glioblastoma is unique because it grows within the brain's neuropeptide-rich environment. Understanding how tumors co-opt these signals could lead to neuropeptide-based therapies that disrupt tumor growth from a completely new angle.
Questions still open
- Could NPY receptor antagonists slow glioblastoma growth?
- Which neuropeptide pathway is the most druggable target in glioblastoma?
- Do neuropeptide levels in cerebrospinal fluid predict glioblastoma aggressiveness?
Common questions
How do brain tumors use neuropeptides?
Could blocking neuropeptides treat brain cancer?
Read the original research
Neuropeptide Signaling in Glioblastoma: A Comprehensive Review of the Current State and Future Direction.
Neuromolecular medicine, 27(1), 27
Citation
Afridi, Shahid; Muzzammil, Mohd; Ali, Intezar; Shahi, Mehdi H. (2025). Neuropeptide Signaling in Glioblastoma: A Comprehensive Review of the Current State and Future Direction.. Neuromolecular medicine, 27(1), 27. https://doi.org/10.1007/s12017-025-08849-x